81 FR 41584 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 123 (June 27, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 123 (June 27, 2016)
| Page Range | 41584-41585 | |
| FR Document | 2016-15064 |
[Federal Register Volume 81, Number 123 (Monday, June 27, 2016)] [Notices] [Pages 41584-41585] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-15064] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Opportunities for Collaborative Research at the NIH Clinical Center. Date: July 20, 2016. Time: 12:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892-7924, 301-435-0725, [email protected]. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Rapid Zika R21. Date: July 21, 2016. Time: 10:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7189, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Stephanie L. Constant, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7189, Bethesda, MD 20892, 301-443-8784, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) [[Page 41585]] Dated: June 21, 2016. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-15064 Filed 6-24-16; 8:45 am] BILLING CODE 4140-01-P
![41584 Federal Register / Vol. 81, No. 123 / Monday, June 27, 2016 / Notices
the IHS and to the HHS Office of addition, Public Law 103–227, the Pro- Dated: June 21, 2016.
Inspector General all information Children Act of 1994, prohibits smoking David Clary,
related to violations of Federal criminal in certain facilities (or in some cases, Program Analyst, Office of Federal Advisory
law involving fraud, bribery, or gratuity any portion of the facility) in which Committee Policy.
violations potentially affecting the regular or routine education, library, [FR Doc. 2016–15060 Filed 6–24–16; 8:45 am]
Federal award. 45 CFR 75.113. day care, health care, or early childhood BILLING CODE 4140–01–P
Disclosures must be sent in writing to: development services are provided to
U.S. Department of Health and children. This is consistent with the
Human Services, Indian Health Service, HHS mission to protect and advance the DEPARTMENT OF HEALTH AND
Division of Grants Management, ATTN: physical and mental health of the HUMAN SERVICES
Robert Tarwater, Director, 5600 Fishers American people.
Lane, Mail Stop: 09E70, Rockville, National Institutes of Health
Dated: June 16, 2016.
Maryland 20857. (Include ‘‘Mandatory Elizabeth A. Fowler,
Grant Disclosures’’ in subject line), National Heart, Lung, and Blood
Office: (301) 443–5204, Fax: (301) 594–
Deputy Director for Management Operations, Institute; Notice of Closed Meetings
Indian Health Service.
0899, Email: Robert.Tarwater@ihs.gov. Pursuant to section 10(d) of the
[FR Doc. 2016–15111 Filed 6–24–16; 8:45 am]
and Federal Advisory Committee Act, as
U.S. Department of Health and BILLING CODE 4165–16–P
amended (5 U.S.C. App.), notice is
Human Services, Office of Inspector hereby given of the following meetings.
General, ATTN: Mandatory Grant The meetings will be closed to the
DEPARTMENT OF HEALTH AND
Disclosures, Intake Coordinator, 330 public in accordance with the
HUMAN SERVICES
Independence Avenue SW., Cohen provisions set forth in sections
Building, Room 5527, Washington, DC National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
20201. URL: http://oig.hhs.gov/fraud/ as amended. The grant applications and
report-fraud/index.asp. (Include National Center for Advancing the discussions could disclose
‘‘Mandatory Grant Disclosures’’ in Translational Sciences; Notice of confidential trade secrets or commercial
subject line), Fax: (202) 205–0604 Closed Meeting property such as patentable material,
(Include ‘‘Mandatory Grant Disclosures’’ and personal information concerning
in subject line) or email: Pursuant to section 10(d) of the
individuals associated with the grant
MandatoryGranteeDisclosures@ Federal Advisory Committee Act, as
applications, the disclosure of which
oig.hhs.gov. amended (5 U.S.C. App.), notice is
would constitute a clearly unwarranted
Failure to make required disclosures hereby given of the following meeting.
invasion of personal privacy.
can result in any of the remedies The meeting will be closed to the
public in accordance with the Name of Committee: National Heart, Lung,
described in 45 CFR 75.371 Remedies and Blood Institute Special Emphasis Panel;
for noncompliance, including provisions set forth in sections
Opportunities for Collaborative Research at
suspension or debarment (See 2 CFR 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
the NIH Clinical Center.
parts 180 & 376 and 31 U.S.C. 3321). as amended. The grant applications and Date: July 20, 2016.
the discussions could disclose Time: 12:30 p.m. to 4:30 p.m.
VII. Agency Contacts confidential trade secrets or commercial Agenda: To review and evaluate grant
1. Questions on the programmatic property such as patentable material, applications.
issues may be directed to: Audrey and personal information concerning Place: National Institutes of Health, 6701
individuals associated with the grant Rockledge Drive, Room 7178, Bethesda, MD
Solimon, Public Health Analyst,
applications, the disclosure of which 20817 (Telephone Conference Call).
National MSPI/DVPI Program Contact Person: William J. Johnson, Ph.D.,
Coordinator, Division of Behavioral would constitute a clearly unwarranted Scientific Review Officer, Office of Scientific
Health, 5600 Fishers Lane, Mail Stop: invasion of personal privacy. Review/DERA, National Heart, Lung, and
08N34–A, Rockville, MD 20857, Phone: Name of Committee: National Center for Blood Institute, 6701 Rockledge Drive, Room
(301) 590–5421, Fax: (301) 594–6213, Advancing Translational Sciences Special 7178, Bethesda, MD 20892–7924, 301–435–
Email: Audrey.Solimon@ihs.gov. Emphasis Panel; Tissue Chip Testing Center. 0725, johnsonwj@nhlbi.nih.gov.
2. Questions on grants management Date: July 26, 2016. Name of Committee: National Heart, Lung,
and fiscal matters may be directed to: Time: 11:00 a.m. to 4:00 p.m. and Blood Institute Special Emphasis Panel;
Donald Gooding, Grants Management Agenda: To review and evaluate grant NHLBI Rapid Zika R21.
applications. Date: July 21, 2016.
Specialist, 5600 Fishers Lane, Mail Place: National Institutes of Health, One Time: 10:00 a.m. to 11:00 a.m.
Stop: 09E70, Rockville, MD 20857, Democracy Plaza, Room 1037, 6701 Agenda: To review and evaluate grant
Phone: (301) 443–2298, Fax: (301) 594– Democracy Boulevard, Bethesda, MD 20892 applications.
0899, Email: Gooding.Donald@ihs.gov. (Telephone Conference Call). Place: National Institutes of Health, 6701
3. Questions on systems matters may Contact Person: Christine A. Livingston, Rockledge Drive, Room 7189, Bethesda, MD
be directed to: Paul Gettys, Grant Ph.D., Scientific Review Officer, Office of 20892 (Telephone Conference Call).
Systems Coordinator, 5600 Fishers Scientific Review, National Center for Contact Person: Stephanie L. Constant,
Lane, Mail Stop: 09E70, Rockville, MD Advancing Translational Sciences (NCATS), Ph.D., Scientific Review Officer, Office of
20857, e3(301) 443–2114; or the DGM National Institutes of Health, 6701 Scientific Review/DERA, National Heart,
Democracy Blvd., Democracy 1, Room 1073, Lung, and Blood Institute, 6701 Rockledge
main line (301) 443–5204, Fax: (301) Bethesda, MD 20892, (301) 435–1348, Drive, Room 7189, Bethesda, MD 20892, 301–
mstockstill on DSK3G9T082PROD with NOTICES
594–0899, Email: Paul.Gettys@ihs.gov. livingsc@mail.nih.gov. 443–8784, constantsl@nhlbi.nih.gov.
VIII. Other Information (Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology, Program Nos. 93.233, National Center for
The Public Health Service strongly Physiology, and Biological Chemistry Sleep Disorders Research; 93.837, Heart and
encourages all cooperative agreement Research; 93.350, B—Cooperative Vascular Diseases Research; 93.838, Lung
and contract recipients to provide a Agreements; 93.859, Biomedical Research Diseases Research; 93.839, Blood Diseases
smoke-free workplace and promote the and Research Training, National Institutes of and Resources Research, National Institutes
non-use of all tobacco products. In Health, HHS) of Health, HHS)
VerDate Sep<11>2014 18:52 Jun 24, 2016 Jkt 238001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1](https://thefederalregister.org/doc/81_FR_41707/page/1.svg)
![Federal Register / Vol. 81, No. 123 / Monday, June 27, 2016 / Notices 41585
Dated: June 21, 2016. limitations imposed by the review and ACTION: Notice.
Michelle Trout, funding cycle.
Program Analyst, Office of Federal Advisory Name of Committee: AIDS and Related SUMMARY: The invention listed below is
Committee Policy. Research Integrated Review Group; owned by an agency of the U.S.
[FR Doc. 2016–15064 Filed 6–24–16; 8:45 am]
Behavioral and Social Consequences of HIV/ Government and is available for
AIDS Study Section. licensing and/or co-development in the
BILLING CODE 4140–01–P Date: July 18–19, 2016. U.S. in accordance with 35 U.S.C. 209
Time: 8:00 a.m. to 5:00 p.m. and 37 CFR part 404 to achieve
Agenda: To review and evaluate grant
DEPARTMENT OF HEALTH AND applications. expeditious commercialization of
HUMAN SERVICES Place: Westin Grand, 2350 M Street NW., results of federally-funded research and
Washington, DC 20037. development. Foreign patent
National Institutes of Health Contact Person: Mark P. Rubert, Ph.D., applications are filed on selected
Scientific Review Officer, Center for inventions to extend market coverage
Center for Scientific Review; Notice of Scientific Review, National Institutes of for companies and may also be available
Closed Meetings Health, 6701 Rockledge Drive, Room 5218, for licensing and/or co-development.
MSC 7852, Bethesda, MD 20892; 301–806–
Pursuant to section 10(d) of the 6596; rubertm@csr.nih.gov. ADDRESSES: Invention Development and
Federal Advisory Committee Act, as Name of Committee: Center for Scientific
Marketing Unit, Technology Transfer
amended (5 U.S.C. App.), notice is Review Special Emphasis Panel; Member Center, National Cancer Institute, 9609
hereby given of the following meetings. Conflict: Topics in Bacterial Pathogenesis Medical Center Drive, Mail Stop 9702,
The meetings will be closed to the and Host Interactions. Rockville, MD 20850–9702.
public in accordance with the Date: July 18, 2016. FOR FURTHER INFORMATION CONTACT:
provisions set forth in sections Time: 10:00 a.m. to 6:00 p.m. Information on licensing and co-
Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., development research collaborations,
applications.
as amended. The grant applications and Place: National Institutes of Health, 6701 and copies of the U.S. patent
the discussions could disclose Rockledge Drive, Bethesda, MD 20892. applications listed below may be
confidential trade secrets or commercial Contact Person:Soheyla Saadi, Ph.D., obtained by contacting: Attn. Invention
property such as patentable material, Scientific Review Officer, Center for Development and Marketing Unit,
and personal information concerning Scientific Review, National Institutes of Technology Transfer Center, National
individuals associated with the grant Health, 6701 Rockledge Drive, Room 3211, Cancer Institute, 9609 Medical Center
applications, the disclosure of which MSC 7808, Bethesda, MD 20892; 301–435– Drive, Mail Stop 9702, Rockville, MD
0903; saadisoh@csr.nih.gov.
would constitute a clearly unwarranted 20850–9702, Tel. 240–276–5515 or
invasion of personal privacy. Name of Committee: Center for Scientific email ncitechtransfer@mail.nih.gov. A
Review Special Emphasis Panel; Member
Name of Committee: Center for Scientific signed Confidential Disclosure
Conflict: Gastrointestinal and Liver
Review Special Emphasis Panel; Pathophysiology and Toxicology. Agreement may be required to receive
Implementation and Dissemination Science Date: July 20–21, 2016. copies of the patent applications.
for HIV/AIDS. Time: 9:00 a.m. to 6:00 p.m. SUPPLEMENTARY INFORMATION:
Date: July 8, 2016. Agenda: To review and evaluate grant Technology description follows.
Time: 10:00 a.m. to 6:30 p.m. applications. Title of invention: Biomarker
Agenda: To review and evaluate grant Place: National Institutes of Health, 6701 signature development: microRNAs as
applications. Rockledge Drive, Bethesda, MD 20892
Place: National Institutes of Health, 6701 (Virtual Meeting).
biodosimetry markers.
Rockledge Drive, Bethesda, MD 20892 Contact Person: Atul Sahai, Ph.D., Description of Technology:
(Virtual Meeting). Scientific Review Officer, Center for Alterations in microRNAs (miRNAs),
Contact Person: Shalanda A Bynum, Ph.D., Scientific Review, National Institutes of a type of small non-coding RNAs, have
MPH, Scientific Review Officer, Center for Health, 6701 Rockledge Drive, Room 2188, been reported in cells/tumors subjected
Scientific Review, National Institutes of MSC 7818, Bethesda, MD 20892; 301–435– to radiation exposure, implying that
Health, 6701 Rockledge Drive, Room 3206, 1198; sahaia@csr.nih.gov. miRNAs play an important role in
Bethesda, MD 20892; 301–755–4355; (Catalogue of Federal Domestic Assistance cellular stress response to radiation.
bynumsa@csr.nih.gov. Program Nos. 93.306, Comparative Medicine; Researchers at the National Cancer
This notice is being published less than 15 93.333, Clinical Research, 93.306, 93.333, Institute evaluated small non-coding
days prior to the meeting due to the timing 93.337, 93.393–93.396, 93.837–93.844, RNAs, long non-coding RNAs (lncRNA),
limitations imposed by the review and 93.846–93.878, 93.892, 93.893, National
funding cycle. Institutes of Health, HHS)
and mRNA as potential non-invasive
biomarkers for radiation biodosimetry.
Name of Committee: Center for Scientific Dated: June 21, 2016.
Review Special Emphasis Panel; Member
While the use of miRNAs as radiation
Sylvia L. Neal, biomarkers has been reported, the
Conflict: Cardiovascular Sciences.
Date: July 13–14, 2016. Program Analyst, Office of Federal Advisory integrated use of miRNAs, mRNAs and
Time: 9:00 a.m. to 5:00 p.m. Committee Policy. lncRNAs to accurately determine
Agenda: To review and evaluate grant [FR Doc. 2016–15054 Filed 6–24–16; 8:45 am] radiation doses is novel and has not
applications. BILLING CODE 4140–01–P been published. The researchers
Place: National Institutes of Health, 6701 characterized a unique method of
Rockledge Drive, Bethesda, MD 20892 examining miRNA levels along with
(Virtual Meeting). DEPARTMENT OF HEALTH AND levels of its target mRNA and lncRNA
mstockstill on DSK3G9T082PROD with NOTICES
Contact Person: Kimm Hamann, Ph.D., HUMAN SERVICES
Scientific Review Officer, Center for
to determine radiation exposure using
Scientific Review, National Institutes of whole blood samples from mice
National Institutes of Health exposed to 2, 4, 8, 12 and 15 Gy
Health, 6701 Rockledge Drive, Room 4118A,
MSC 7814, Bethesda, MD 20892; 301–435– irradiation. In doing so, they discovered
Government-Owned Inventions;
5575; hamannkj@csr.nih.gov. distinct miRNA, mRNA and lncRNA
Availability for Licensing
This notice is being published less than 15 biomarker signatures that inform degree
days prior to the meeting due to the timing AGENCY: National Institutes of Health. of radiation exposure.
VerDate Sep<11>2014 18:52 Jun 24, 2016 Jkt 238001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM 27JNN1](https://thefederalregister.org/doc/81_FR_41707/page/2.svg)
Document Created: 2016-06-25 02:07:21
Document Modified: 2016-06-25 02:07:21
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | July 20, 2016. | |
| FR Citation | 81 FR 41584 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR